Multi-omics cohort analysis and biobank construction in Japanese patients with inflammatory bowel disease

Multi-omics cohort analysis and biobank construction in Japanese patients with inflammatory bowel disease - IBD-MOCHA

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046841

Enrollment

5500

Registered

2022-03-31

Start date

2022-03-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inflammatory bowel disease (Crohn's disease, ulcerative colitis, unclassifiable enteritis) or suspected cases

Exclusion criteria

Exclusion criteria: Cases in which the cause of enteritis symptoms is obvious (infectious enteritis, ischemic enteritis, diverticulitis, etc.) Other cases that the attending physician considers inappropriate

Design outcomes

Primary

Measure	Time frame
Genetic factors involved in pathogenesis	—

Secondary

Measure	Time frame
Serum proteins, gut microbiota, and genetic background related to prognosis and pathology	—

Countries

Japan

Contacts

Public ContactYoichi Kakuta

Tohoku University Hospital Division of Gastroenterology

ykakuta@med.tohoku.ac.jp0227177171

Outcome results